These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33826786)

  • 41. Progenitor-cell-enriched micrografts as a novel option for the management of androgenetic alopecia.
    Ruiz RG; Rosell JMC; Ceccarelli G; De Sio C; De Angelis GC; Pinto H; Astarita C; Graziano A
    J Cell Physiol; 2020 May; 235(5):4587-4593. PubMed ID: 31643084
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
    Gassmueller J; Hoffmann R; Webster A
    Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of topical minoxidil therapy for androgenetic alopecia in women.
    Jacobs JP; Szpunar CA; Warner ML
    Int J Dermatol; 1993 Oct; 32(10):758-62. PubMed ID: 8225725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MR Imaging of Hair and Scalp for the Evaluation of Androgenetic Alopecia.
    Soga S; Koyama T; Mikoshi A; Arafune T; Kawashima M; Kobayashi K; Shinmoto H
    Magn Reson Med Sci; 2021 Jun; 20(2):160-165. PubMed ID: 32378681
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial.
    Shin HS; Won CH; Lee SH; Kwon OS; Kim KH; Eun HC
    Am J Clin Dermatol; 2007; 8(5):285-90. PubMed ID: 17902730
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Contrast enhanced phototrichogram pinpoints scalp hair changes in androgen sensitive areas of male androgenetic alopecia.
    Leroy T; Van Neste D
    Skin Res Technol; 2002 May; 8(2):106-11. PubMed ID: 12060475
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microneedling in androgenetic alopecia; comparing two different depths of microneedles.
    Faghihi G; Nabavinejad S; Mokhtari F; Fatemi Naeini F; Iraji F
    J Cosmet Dermatol; 2021 Apr; 20(4):1241-1247. PubMed ID: 32897622
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomized, double-blind, vehicle-controlled clinical study of hair regeneration using adipose-derived stem cell constituent extract in androgenetic alopecia.
    Tak YJ; Lee SY; Cho AR; Kim YS
    Stem Cells Transl Med; 2020 Aug; 9(8):839-849. PubMed ID: 32420695
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of androgenetic alopecia in females in reproductive age with topical estradiolbenzoate, prednisolon and salicylic acid.
    Abadjieva TI
    Folia Med (Plovdiv); 2000; 42(3):26-9. PubMed ID: 11347332
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia.
    Whiting DA
    J Am Acad Dermatol; 1993 May; 28(5 Pt 1):755-63. PubMed ID: 8496421
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.
    Gubelin Harcha W; Barboza Martínez J; Tsai TF; Katsuoka K; Kawashima M; Tsuboi R; Barnes A; Ferron-Brady G; Chetty D
    J Am Acad Dermatol; 2014 Mar; 70(3):489-498.e3. PubMed ID: 24411083
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multi-therapies in androgenetic alopecia: review and clinical experiences.
    Rossi A; Anzalone A; Fortuna MC; Caro G; Garelli V; Pranteda G; Carlesimo M
    Dermatol Ther; 2016 Nov; 29(6):424-432. PubMed ID: 27424565
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antiandrogenic Therapy with Ciproterone Acetate in Female Patients Who Suffer from Both Androgenetic Alopecia and Acne Vulgaris.
    Coneac A; Muresan A; Orasan MS
    Clujul Med; 2014; 87(4):226-34. PubMed ID: 26528029
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Videodermatoscopy enhances diagnostic capability in some forms of hair loss.
    Lacarrubba F; Dall'Oglio F; Rita Nasca M; Micali G
    Am J Clin Dermatol; 2004; 5(3):205-8. PubMed ID: 15186200
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of a cosmetic phyto-caffeine shampoo in female androgenetic alopecia.
    Bussoletti C; Tolaini MV; Celleno L
    G Ital Dermatol Venereol; 2020 Aug; 155(4):492-499. PubMed ID: 29512972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Original article: Platelet-rich plasma with microneedling in androgenetic alopecia along with dermoscopic pre- and post-treatment evaluation.
    Jha AK; Udayan UK; Roy PK; Amar AKJ; Chaudhary RKP
    J Cosmet Dermatol; 2018 Jun; 17(3):313-318. PubMed ID: 28771982
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Growth factor concentrations in platelet-rich plasma for androgenetic alopecia: An intra-subject, randomized, blinded, placebo-controlled, pilot study.
    Siah TW; Guo H; Chu T; Santos L; Nakamura H; Leung G; Shapiro J; McElwee KJ
    Exp Dermatol; 2020 Mar; 29(3):334-340. PubMed ID: 31984508
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autologous Concentrated Growth Factors Combined with Topical Minoxidil for the Treatment of Male Androgenetic Alopecia: A Randomized Controlled Clinical Trial.
    Tan PC; Zhang PQ; Xie Y; Gao YM; Li QF; Zhou SB; Liu Q; Liu K
    Facial Plast Surg Aesthet Med; 2021; 23(4):255-262. PubMed ID: 32833539
    [No Abstract]   [Full Text] [Related]  

  • 59. Efficacy and Safety of a Low-Level Light Therapy for Androgenetic Alopecia: A 24-Week, Randomized, Double-Blind, Self-Comparison, Sham Device-Controlled Trial.
    Mai-Yi Fan S; Cheng YP; Lee MY; Lin SJ; Chiu HY
    Dermatol Surg; 2018 Nov; 44(11):1411-1420. PubMed ID: 29957664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Efficacy and tolerability of 5% minoxidil solution (Carexidil®) in male and female androgenetic alopecia: a 6-month open multicentric study].
    Piraccini B; Starace M; Alessandrini A; Guarrera M; Fiorucci MC; Lorenzi S
    G Ital Dermatol Venereol; 2011 Dec; 146(6 Suppl 1):1-8. PubMed ID: 22189834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.